Detects Apdn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Message :
Required fields
Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing
Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactful Variants of SARS-CoV-2
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the launch of its Linea™ COVID-19 Selective Genomic Surveillance™ (SGS) Mutation Panel (the “SGS Panel”) to enhance the utility of limited Next Generation Sequencing (NGS) resources in the United States to track better the SARS-CoV-2 Variants of Concern (VOCs) at local, state, and federal levels. The SGS Panel uses a matrix of proprietary quantitative polymerase chain reaction (qPCR) assays that target salient mutations that characterize relevant identified VOCs to narrow the selection of positive samples worth sub ....

United States , James Hayward , Mutation Panel , Sciences Inc , Research Use Only , Clinical Laboratory Improvement Amendments , Company Linea , Clinical Laboratory News , Polymerase Chain Reaction , Genomic Surveillance , Next Generation Sequencing , Genetic Engineering , Biotechnology News , Assay Kit , Russell Microcap , Applied Dna Sciences , Inc Stock Exchange , Press Release , Detects Apdn , ஒன்றுபட்டது மாநிலங்களில் , ஜேம்ஸ் வைக்கோல் , பிறழ்வு குழு , அறிவியல் இன்க் , ஆராய்ச்சி பயன்பாடு மட்டும் , மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் , நிறுவனம் வரி ,